Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07504341

Physiological Finding in Management of COVID 19 Patients

This study utilizes physiological indicators of COVID-19 patients as tools for assessing, tracking, worsening, and improving the clinical symptoms of COVID-19 patients. This study employs simple and easy-to-use assessment methods, which can be further aided by artificial intelligence technology to facilitate early response and medication.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

COVID-19 (Coronavirus Disease 2019) COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

St. Martin De Porres Hospital, Chiayi City, Taiwan

Loading trial locations.

About this study

This study utilizes physiological indicators of COVID-19 patients, such as blood pressure, heart rate, respiratory rate, and level of consciousness, to develop Shock Index (SI), Mordified Shock Index (MSI), Age Shock Index (Age SI), Age Mordified Shock Index (Age MSI), and Respiratory Adjusted Shock Index (RASI), as well as other physiological indicators, as tools for assessing, tracking, worsening, and improving the clinical symptoms of COVID-19 patients. For patients with mild to severe illness, and in response to the shortage of manpower during a large influx of emergency patients, this study employs simple and easy-to-use assessment methods, which can be further aided by artificial intelligence technology to facilitate early response and medication.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Reviewing the patient's medical history, the primary focus was on hospital records and existing physiological parameters such as blood pressure, heart rate, respiratory rate, and level of consciousness. The patient received treatment at the hospital between May 2022 and March 2027

Exclusion criteria

  • Excluding patients with incomplete clinical data or missing information in their medical records.

Treatment and study plan

physiological parameters

Other

systolic blood pressure, diastolic blood pressure , heart rate, respiratory rate , GCS

Primary outcomes

  1. Shock index(SI) in the management of COVID -19

    Time frame: 2022 May to 2027 March

    SI= heart rate / systolic blood pressre

  2. Mordified shock index(MSI) in the management of COVID -19

    Time frame: 2022 May to 2027 March

    MSI=heart rate / mean arterial pressure

  3. Age shock index(Age SI) in the management of COVID -19

    Time frame: 2022 May to 2027 March

    Age shock index =Age x (heart rate / systolic blood pression)

  4. Respiratory adjusted shock index (RASI) in the management of COVID-19

    Time frame: 2022 may to 2027 March

    Respiratory adjusted shock index =(heart rate/systolic blood pression) x (repiratory rate/10)

Study contacts

Contact information is provided by the study sponsor or research team.

Chia-Hsi Chen

CONTACT

[email protected]

886-5-2756000 ext. 3708

Chia-Hsi Chen, Physician

CONTACT

[email protected]

886-5-2756000 ext. 3708

Sponsors and collaborators

Lead sponsor

St. Martin De Porress Hospital

Other

Registry information

Official study title

The Combined Usage of Clinical Physiological Finding in Management of COVID 19 Patients

Acronym: COVID-19

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Mar 31, 2026
Registry last updated
Mar 31, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.